Tufts Medical Center:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tufts Medical Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5162
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tufts Medical Center (TMC), formerly New England Medical Center Hospital Inc, a subsidiary of Tufts University School of Medicine, is an academic medical center that provides patient care services. The center offers treatments for brain tumor, breast cancer, cardiac arrhythmia, cardiomyopathy, celiac disease, cervical cancer, epilepsy, heart disease, in vitro-fertilization, urinary incontinence, and urological cancer. It provides medical services in allergy, anesthesiology, dermatology, emergency services, internal medicine and adult primary care, weight and wellness center, and others. TMC offers advanced pediatric care to children of all ages, from babies born before their due dates to maturing adolescents. It also performs research and provides training services. TMC is headquartered in Boston, Massachusetts, the US.

Tufts Medical Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tufts Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tufts Medical Center, Medical Devices Deals, 2012 to YTD 2018 9
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tufts Medical Center, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Tracon Pharma Enters into Research Agreement with Tufts Medical Center 11
Tufts Medical Center to Form Joint Venture with Lowell General Hospital 13
Tufts Medical Center Forms Joint Venture with Aton Partners 14
Pepticom Enters into Co-Development Agreement with Tufts Medical Center 15
Tufts Medical Center, Vanguard Health And New England Quality Care Partner For New Healthcare System 16
Debt Offering 17
Tufts Medical Center Announces Public Offering Of Bonds For US$100 Million 17
Tufts Medical Center – Key Competitors 18
Tufts Medical Center – Key Employees 19
Tufts Medical Center – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 21
Recent Developments 22
Government and Public Interest 22
May 07, 2018: Tufts Clinical and Translational Science Institute (CTSI) receives $56 Million National Institutes of Health (NIH) Clinical and Translational Science Award 22
Mar 30, 2018: New Research Award by Fisher & Paykel Healthcare to Benefit COPD Patients 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Tufts Medical Center, Pharmaceuticals & Healthcare, Key Facts 2
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tufts Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tufts Medical Center, Deals By Therapy Area, 2012 to YTD 2018 8
Tufts Medical Center, Medical Devices Deals, 2012 to YTD 2018 9
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tracon Pharma Enters into Research Agreement with Tufts Medical Center 11
Tufts Medical Center to Form Joint Venture with Lowell General Hospital 13
Tufts Medical Center Forms Joint Venture with Aton Partners 14
Pepticom Enters into Co-Development Agreement with Tufts Medical Center 15
Tufts Medical Center, Vanguard Health And New England Quality Care Partner For New Healthcare System 16
Tufts Medical Center Announces Public Offering Of Bonds For US$100 Million 17
Tufts Medical Center, Key Competitors 18
Tufts Medical Center, Key Employees 19
Tufts Medical Center, Other Locations 20
Tufts Medical Center, Subsidiaries 20
Tufts Medical Center, Joint Venture 21

List of Figures
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tufts Medical Center, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Tufts Medical Center:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • WInco Foods LLC:戦略・SWOT・企業財務分析
    WInco Foods LLC - Strategy, SWOT and Corporate Finance Report Summary WInco Foods LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Scienion AG-医療機器分野:企業M&A・提携分析
    Summary Scienion AG (Scienion) is a life science company that offers solutions for liquid dispensing applications. The company’s products include scireader cl, innoscan microarray scanners, sciflexarrayer, sciliner lateral flow dispenser, sciconsumables- sciplexplates 96, scichip, scibuffer, scihybc …
  • Avista Corp (AVA):企業の財務・戦略的SWOT分析
    Avista Corp (AVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Telkom SA SOC Limited (TKG):企業の財務・戦略的SWOT分析
    Telkom SA SOC Limited (TKG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • General Dynamics Ordnance and Tactical Systems, Inc.:企業の戦略・SWOT・財務情報
    General Dynamics Ordnance and Tactical Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary General Dynamics Ordnance and Tactical Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • Jamaica Public Service Co Ltd:企業の戦略的SWOT分析
    Jamaica Public Service Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Goldin Properties Holdings Ltd:企業の戦略・SWOT・財務情報
    Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Baron Oil Plc (BOIL):企業の財務・戦略的SWOT分析
    Summary Baron Oil Plc (Baron Oil), formerly Gold Oil PLC is an oil and gas exploration and production company. The company identifies and develops crude oil and natural gas interests in Latin America including Peru and Colombia. It also holds working interests of Nancy Burdine Maxine oil field, oil …
  • Royal Mail plc (RMG):企業の財務・戦略的SWOT分析
    Royal Mail plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Industrias Penoles SAB de CV:企業の戦略・SWOT・財務情報
    Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • OraMetrix Inc-医療機器分野:企業M&A・提携分析
    Summary OraMetrix Inc (OraMetrix) is a healthcare technology company that provides 3-D technology solutions. The company offers orthodontic treatment system and digital lingual orthodontic system. Its product allows the use of precision digital tools throughout the orthodontic treatment process incl …
  • Dunavant Enterprises, Inc.:企業の戦略・SWOT・財務分析
    Dunavant Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dunavant Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Petroliam Nasional Berhad:企業の戦略・SWOT・財務分析
    Petroliam Nasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Petroliam Nasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Vedanta Resources Ltd:企業の戦略的SWOT分析
    Vedanta Resources Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Innovus Pharmaceuticals Inc (INNV)-製薬・医療分野:企業M&A・提携分析
    Summary Innovus Pharmaceuticals Inc (Innovus Pharmaceuticals), formerly North Horizon Inc is a pharmaceutical company that commercialize, license and develops over-the-counter and consumer healthcare products. The company’s product portfolio comprises BTH testosterone booster; Zestra for female arou …
  • Host Hotels & Resorts Inc (HST):企業の財務・戦略的SWOT分析
    Host Hotels & Resorts Inc (HST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Surgical Care Affiliates LLC:医療機器:M&Aディール及び事業提携情報
    Summary Surgical Care Affiliates LLC (SCA), a subsidiary of UnitedHealth Group Inc is a healthcare organization that offers patient care and healthcare services. The organization's services include scheduling optimization, physician governance and engagement, case costing, profitability analysis and …
  • Cowen Inc:企業の戦略・SWOT・財務情報
    Cowen Inc - Strategy, SWOT and Corporate Finance Report Summary Cowen Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • The Israel Electric Corporation Ltd-エネルギー分野:企業M&A・提携分析
    Summary The Israel Electric Corporation Ltd (IECL), formerly Palestine Electric Corporation Ltd. is an integrated electric utility that carries out the generation, transmission, distribution, sale and supply of electricity. The State of Israel owns around 99.85% of the company. It generates power ma …
  • Neos Therapeutics Inc (NEOS):製薬・医療:M&Aディール及び事業提携情報
    Summary Neos Therapeutics Inc (Neos Therapeutics), formerly Neostx Inc, develops, manufactures, and commercializes branded pharmaceuticals. The company’s portfolio includes Adzenys XR-ODT that is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in patients of six years …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆